Past, present, and future efforts to enhance the efficacy of cord blood hematopoietic cell transplantation [version 1; peer review: 3 approved]
Cord blood (CB) has been used as a viable source of hematopoietic stem cells (HSCs) and hematopoietic progenitor cells (HPCs) in over 35,000 clinical hematopoietic cell transplantation (HCT) efforts to treat the same variety of malignant and non-malignant disorders treated by bone marrow (BM) and mo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2019-10-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/8-1833/v1 |